Cytogen Price To Sales vs. Debt To Equity
| 217330 Stock | KRW 4,300 330.00 8.31% |
For Cytogen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cytogen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cytogen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cytogen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cytogen over time as well as its relative position and ranking within its peers.
Cytogen |
Cytogen Debt To Equity vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cytogen's current stock value. Our valuation model uses many indicators to compare Cytogen value to that of its competitors to determine the firm's financial worth. Cytogen is number one stock in price to sales category among its peers. It also is number one stock in debt to equity category among its peers . The ratio of Price To Sales to Debt To Equity for Cytogen is about 1,460 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cytogen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cytogen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cytogen Debt To Equity vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Cytogen |
| = | 487.61 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Cytogen |
| = | 0.33 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Cytogen Debt To Equity Comparison
Cytogen is currently under evaluation in debt to equity category among its peers.
Cytogen Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cytogen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cytogen will eventually generate negative long term returns. The profitability progress is the general direction of Cytogen's change in net profit over the period of time. It can combine multiple indicators of Cytogen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment and downstream systems to treat cancer in South Korea. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea. Cytogen is traded on Korean Securities Dealers Automated Quotations in South Korea.
Cytogen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cytogen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cytogen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cytogen's important profitability drivers and their relationship over time.
Use Cytogen in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytogen will appreciate offsetting losses from the drop in the long position's value.Cytogen Pair Trading
Cytogen Pair Trading Analysis
The ability to find closely correlated positions to Cytogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytogen to buy it.
The correlation of Cytogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Cytogen position
In addition to having Cytogen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Casinos Thematic Idea Now
Casinos
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Cytogen Stock
To fully project Cytogen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cytogen at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cytogen's income statement, its balance sheet, and the statement of cash flows.